An open-label study evaluating the efficacy of abatacept in alopecia areata - 15/02/21
Dr Mackay-Wiggan is currently affiliated with the Siperstein Dermatology Group, Boca Raton, Florida. Dr Sallee is currently affiliated with the Department of Dermatology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma. Dr Sansaricq is currently affiliated with the Department of Internal Medicine, North Shore University Hospital, Manhasset, New York. Dr Nguyen is currently affiliated with the Schweiger Dermatology Group, New York, New York. Dr Kim is currently affiliated with the Department of Dermatology, New York Medical College, New York, New York. Dr Clynes is currently affiliated with Xencor Inc, Monrovia, California. |
|
Funding sources: Supported by Locks of Love Foundation and National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R21AR061881, U01AR067173, K08AR069111, and P50AR070588). Study drug was provided by Bristol Myers Squibb. |
|
Conflicts of interest: None declared. |
|
IRB approval status: Approved by Columbia University IRB-AAAK2167. |
Vol 84 - N° 3
P. 841-844 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?